Plasmablastic lymphoma with unfavorable chromosomal abnormalities related to plasma cell myeloma: A borderline case between plasmablastic lymphoma and plasmablastic plasma cell myeloma.
作者信息
Aoyama Yumi, Tsunemine Hiroko, Kodaka Taiichi, Oda Nao, Matsuoka Hirofumi, Itoh Tomoo, Takahashi Takayuki
机构信息
Departments of Hematology, Shinko Hospital.
Respiratory Medicine, Shinko Hospital.
出版信息
J Clin Exp Hematop. 2017;57(1):37-39. doi: 10.3960/jslrt.16020.
Abstract
摘要
相似文献
1
Plasmablastic lymphoma with unfavorable chromosomal abnormalities related to plasma cell myeloma: A borderline case between plasmablastic lymphoma and plasmablastic plasma cell myeloma.
J Clin Exp Hematop. 2017;57(1):37-39. doi: 10.3960/jslrt.16020.
2
Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features.
Mod Pathol. 2010 Jul;23(7):991-9. doi: 10.1038/modpathol.2010.72. Epub 2010 Mar 26.
3
Lymphoid Neoplasms With Plasmablastic Differentiation: A Comprehensive Review and Diagnostic Approaches.
Adv Anat Pathol. 2020 Mar;27(2):61-74. doi: 10.1097/PAP.0000000000000253.
4
Plasmablastic lymphoma versus anaplastic myeloma in a human immunodeficiency virus negative male: a diagnostic quandary.
Arch Iran Med. 2013 Oct;16(10):608-10.
5
Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma.
Virchows Arch. 2022 Aug;481(2):283-293. doi: 10.1007/s00428-022-03342-3. Epub 2022 Jun 3.
6
CD31 expression in plasmacytic/plasmablastic lesions.
Ann Diagn Pathol. 2013 Dec;17(6):498-501. doi: 10.1016/j.anndiagpath.2013.08.003. Epub 2013 Sep 24.
7
[Plasmablastic myeloma initially presented with ascites].
Rinsho Ketsueki. 2022;63(3):194-200. doi: 10.11406/rinketsu.63.194.
8
Cutaneous localization of plasmablastic multiple myeloma with heterotopic expression of CD3 and CD4: Skin involvement revealing systemic disease.
J Cutan Pathol. 2019 Aug;46(8):619-622. doi: 10.1111/cup.13486. Epub 2019 May 10.
9
[Plasmablastic lymphoma presenting clinical symptoms similar to plasmablastic myeloma].
Rinsho Ketsueki. 2023;64(4):260-264. doi: 10.11406/rinketsu.64.260.
10
Plasmablastic haemato-lymphoid neoplasm with a complex genetic signature of Burkitt lymphoma responding to bortezomib.
Hematol Oncol. 2013 Sep;31(3):164-6. doi: 10.1002/hon.2024. Epub 2012 Aug 17.
引用本文的文献
1
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy.
Nat Med. 2024 Apr;30(4):984-989. doi: 10.1038/s41591-024-02826-w. Epub 2024 Jan 24.
2
Case report: simultaneous occurrence of multiple myeloma and non-Hodgkin lymphoma treated by CAR T therapy.
Medicine (Baltimore). 2020 Apr;99(16):e19739. doi: 10.1097/MD.0000000000019739.
本文引用的文献
1
Plasmablastic Lymphoma: A Review of Clinicopathologic Features and Differential Diagnosis.
Arch Pathol Lab Med. 2016 Oct;140(10):1074-8. doi: 10.5858/arpa.2016-0232-RA.
2
Extramedullary manifestation in multiple myeloma bears high incidence of poor cytogenetic aberration and novel agents resistance.
Biomed Res Int. 2015;2015:787809. doi: 10.1155/2015/787809. Epub 2015 Apr 23.
3
The biology and treatment of plasmablastic lymphoma.
Blood. 2015 Apr 9;125(15):2323-30. doi: 10.1182/blood-2014-10-567479. Epub 2015 Jan 30.
4
Long-term analysis of the IFM 99 trials for myeloma: cytogenetic abnormalities [t(4;14), del(17p), 1q gains] play a major role in defining long-term survival.
J Clin Oncol. 2012 Jun 1;30(16):1949-52. doi: 10.1200/JCO.2011.36.5726. Epub 2012 Apr 30.
5
Plasmablastic lymphoma: a systematic review.
ScientificWorldJournal. 2011 Mar 22;11:687-96. doi: 10.1100/tsw.2011.59.
6
Plasmablastic lymphoma in an immunocompetent patient.
J Clin Oncol. 2009 Sep 1;27(25):e78-81. doi: 10.1200/JCO.2009.22.2208. Epub 2009 Jul 6.
7
BCL6 gene amplification/3q27 gain is associated with unique clinicopathological characteristics among follicular lymphoma without BCL2 gene translocation.
Mod Pathol. 2008 Aug;21(8):973-8. doi: 10.1038/modpathol.2008.75. Epub 2008 May 23.
8
Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles.
Mod Pathol. 2005 Jun;18(6):806-15. doi: 10.1038/modpathol.3800355.
9
HIV and plasmablastic lymphoma manifesting in sinus, testicles, and bones: a further expansion of the disease spectrum.
Am J Hematol. 2004 Nov;77(3):291-5. doi: 10.1002/ajh.20190.
10
Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma.
Blood. 1998 Sep 1;92(5):1743-8.
Zotero 插件